STAT

Alex Azar, Trump’s HHS nominee, says addressing drug prices would be his top priority

The message was aimed directly at Democrats and consumer groups, who have questioned whether he would deliver on Trump's promise to bring down prices.
Alex Azar, President Trump's pick to lead HHS.

WASHINGTON — Alex Azar, President Trump’s pick to lead the Health and Human Services Department, didn’t mince words when he described his top priority for the agency, telling lawmakers Wednesday that drug prices are too high and must be lowered.

“The president has made this clear, so have I,” Azar said.

The message was aimed directly at Democrats and critical consumer groups, who have questioned whether Azar would use his post to deliver on Trump’s campaign promise to bring down in particular.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks